Pre-exposure prophylaxis for HIV in Brazil: hopes and moral panic in the social construction of a biomedical technology

References

• Aggleton, P, and R. Parker. 2015. “Moving Beyond Biomedicalization in the HIV Response: Implications for Community Involvement and Community Leadership Among Men Who Have Sex with Men and Transgender People.” American Journal of Public Health 105 (8): 1552–1558.
   PubMed Web of Science ®Google Scholar
• Bastos, L, and M. Ventura. 2017. “Yep, I'm a Truvada Whore’: Ativismo e Cidadania Biológica na Era das Novas Estratégias de Prevenção do HIV/AIDS.” METAXY: Revista Brasileira de Cultura e Políticas em Direitos Humanos 1 (2): 1–21. https://revistas.ufrj.br/index.php/metaxy/article/view/12333
   Google Scholar
• Biehl, J. G. 2007. “Pharmaceuticalization: AIDS Treatment and Global Health Politics.” Anthropological Quarterly 80 (4): 1083–1126.
   Web of Science ®Google Scholar
• Brigeiro, M, and I. Maksud. 2009. “Aparição do Viagra na Cena Pública Brasileira: Discursos sobre Corpo, Gênero e Sexualidade na Mídia.” Revista Estudos Feministas 17 (1): 71–88
   Google Scholar
• Cáceres, C. F., F. Koechlin, P. Goicochea, P.-S. Sow, K. R. O'Reilly, K. H. Mayer, and P. Godfrey-Faussett. 2015. “The Promises and Challenges of Pre-exposure Prophylaxis as Part of the Emerging Paradigm of Combination HIV Prevention.” Journal of the International AIDS Society 18 (4 Suppl 3): 19949.
   PubMedGoogle Scholar
• Clarke, A. E., J. Fishman, J. Fosket, L. Mamo, and J. Shim. 2003. “Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine.” American Sociological Review 68 (2): 161–194.
   Web of Science ®Google Scholar
• Cohen, S. 1972. Folk Devils and Moral Panics. London: MacGibbon and Kee.
   Google Scholar
• Fishman, J. R. 2004. “Manufacturing Desire: The Commodification of Female Sexual Dysfunction.” Social Studies of Science 34 (2): 187–218.
   PubMed Web of Science ®Google Scholar
• Giami, A, and C. Perrey. 2012. “Transformations in the Medicalization of Sex: HIV Prevention from Discipline to Biopolitics.” Journal of Sex Research 49 (4): 353–361.
   PubMed Web of Science ®Google Scholar
• Hartley, H. 2006. “The ‘Pinking’ of Viagra Culture: Drug Industry Efforts to Create and Repackage Sex Drugs for Women.” Sexualities 9 (3): 363–378.
   Google Scholar
• Herzlich, C, and J. Pierret. 1992. “Uma Doença no Espaço Público, a AIDS em Seis Jornais Franceses.” Physis: Revista de Saúde Coletiva 2 (1): 7–35.
   Google Scholar
• Holt, M., C. E. Newman, K. Lancaster, A. K. Smith, S. Hughes, and H.-H M. Truong. 2019. “HIV Pre-exposure Prophylaxis and the ‘Problems’ of Reduced Condom Use and Sexually Transmitted Infections in Australia.” Sociology of Health & Illness 41 (8): 1535–1548.
   PubMed Web of Science ®Google Scholar
• Kenworthy, N., M. Thomann, and R. Parker. 2018. “From a Global Crisis to the ‘End of AIDS’: New Epidemics of Signification.” Global Public Health 13 (8): 960–971.
   PubMed Web of Science ®Google Scholar
• Leibing, A, and V. Tournay. 2010. Introduction. In Les Technologies de L’espoir: La Fabrique d’une Histoire à Accomplir, edited by Leibing, A. and Tournay, V., 24–36. Québec: Presses de l’Université Laval.
   Google Scholar
• Loe, M. 2001. “Fixing Broken Masculinity: Viagra as a Technology for the Production of Gender and Sexuality.” Sexuality and Culture 5 (3): 97–125.
   Google Scholar
• Manica, D. T. 2012. “A Vida Social dos Medicamentos: Etnografias e Escolhas.” Revista de Antropologia da UFSCar 4 (1): 176–188.
   Google Scholar
• Matthews, L., J. Smit, S. Cu-Uvin, and D. Cohan. 2012. “Antiretrovirals and Safer Conception for HIV-serodiscordant Couples.” Current Opinion in HIV and AIDS 7 (6): 569–578.
   PubMed Web of Science ®Google Scholar
• Monteiro, S., M. Brigeiro, C. Mora, W. Vilella, and R. Parker. 2019. “A Review of HIV Testing Strategies among MSM (2005-2015): Changes and Continuities Due to the Biomedicalization of Responses to AIDS.” Global Public Health 14 (5): 764–776.
   PubMed Web of Science ®Google Scholar
• Montgomery, C. M. 2012. “Making Prevention Public: The Co-production of Gender and Technology in HIV Prevention Research.” Social Studies of Science 42 (6): 922–944.
   Web of Science ®Google Scholar
• Nguyen, V.-K., N. Bajos, F. Dubois-Arber, J. O'Malley, and C. M. Pirkle. 2011. “Remedicalizing an Epidemic: From HIV Treatment as Prevention to HIV Treatment is Prevention.” AIDS (London, England) 25 (3): 291–293.
   PubMed Web of Science ®Google Scholar
• Novas, C. 2006. “The Political Economy of Hope: Patients’ Organizations, Science and Biovalue.” BioSocieties 1 (3): 289–305.
   Google Scholar
• Oscar, R. 2019. “Pílulas Diárias Anti-HIV: A Construção de uma Narrativa Antropológica sobre a PreP.” [Daily Anti-HIV Drug. The Construction of an Anthropological Narrative on HIV Pre-exposure Prophylaxis (PrEP)].” PhD diss., Institute for Social Medicine of the State University of Rio de Janeiro.
   Google Scholar
• Paim, J., C. Travassos, C. Almeida, L. Bahia, and J. Macinko. 2011. “The Brazilian Health System: History, Advances and Challenges.” Lancet 26 (3): 461–471.
   Google Scholar
• Preciado, P. 2015. “Condoms Chimiques”. Libération 11. https://www.liberation.fr/chroniques/2015/06/11/condoms-chimiques_1327747
   Google Scholar
• Rabinow, P, and N. Rose. 2006. “Biopower Today.” BioSocieties 1 (2): 195–217.
   Google Scholar
• Race, K. 2018. The Gay Science: Intimate Experiments with the Problem of HIV. London: Routledge.
   Google Scholar
• Savasi, V., L. Mandia, A. Laoreti, and I. Cetin. 2013. “Reproductive Assistance in HIV Serodiscordant Couples.” Human Reproduction Update 19 (2): 136–150.
   PubMed Web of Science ®Google Scholar
• Treichler, P. 1987. “AIDS, Homophobia and Biomedical Discourse: An Epidemic of Signification.” Cultural Studies 1 (3): 263–305.
   Web of Science ®Google Scholar
• Torres-Cruz, C, and E. Suárez-Díaz. 2020. “The Stratified Biomedicalization of HIV Prevention in Mexico City.” Global Public Health 15 (4): 598–610.
   PubMed Web of Science ®Google Scholar
• UNAIDS 2014. Sex workers’ Hopes and Fears for HIV Pre-exposure Prophylaxis: Recommendations from a UNAIDS Consultation. Accessed on 12 December, 2021. https://www.avac.org/resource/sex-workers-hopes-and-fears-hiv-pre-exposure-prophylaxis-recommendations-unaids
   Google Scholar
• UNAIDS 2015. Oral Pre-exposure Prophylaxis. Putting a New Choice in Context. Accessed on 12 December, 2021. https://www.unaids.org/en/resources/documents/2015/Oral_preexposure_prophylaxis_putting_a_new_choice_in_context
   Google Scholar
• UNAIDS 2016. Oral Pre-exposure Prophylaxis. Questions and Answers. Accessed on 12 December, 2021. https://www.unaids.org/en/resources/documents/2015/Oral_preexposure_prophylaxis_questions_and_answers
   Google Scholar
• UNAIDS 2021. Global AIDS Strategy 2021-2026 - End Inequalities. End AIDS. Accessed on 16 December, 2021 https://www.unaids.org/en/resources/documents/2021/2021-2026-global-AIDS-strategy
   Google Scholar
• Van der Geest, S., S. R. Whyte, and A. Hardon. 1996. “The Anthropology of Pharmaceuticals: A Biographical Approach.” Annual Review of Anthropology 25 (1): 153–178.
   Google Scholar
• World Health Organization 2012. Guidance on Oral Pre-exposure Prophylaxis (PrEP) for Serodiscordant Couples, Men and Transgender Women Who Have Sex with Men at High Risk of HIV: Recommendations for Use in the Context of Demonstration Projects. Geneva: WHO.
   Google Scholar
• World Health Organization 2015. Policy Brief: WHO Expands Recommendation on Oral Pre-exposure Prophylaxis of HIV Infection (PrEP). Geneva: WHO.
   Google Scholar
• World Health Organization 2019. Technical Brief: What’s the 2 + 1+1? Event-Driven Oral Pre-exposure Prophylaxis to Prevent HIV for Men who Have Sex with Men: Update to WHO's Recommendation on Oral PrEP. Geneva: WHO.
   Google Scholar